Aristoteles Giagounidis — Prof., Dr. med., oncologist and haematologist
Professor Dr. med. Aristoteles Giagounidis, Head of the Clinic for Oncology, Haematology and Palliative Medicine, and a specialist in lung tumour treatment is included in the list of leading doctors in Germany in the annual survey by FOCUS magazine.
Professor Dr. med., Head of the Clinic for Oncology, Haematology and Palliative Medicine.
Key achievements
- Recognised as one of Germany’s leading doctors for leukaemia and lymphoma by “Good Doctors for Me”.
- Listed among Germany’s leading doctors for lung cancer treatment by FOCUS magazine.
Main research areas
- New approaches to treating myelodysplastic syndromes.
- Acute myeloid leukaemia.
- Immune thrombocytopenia.
- Non-Hodgkin lymphoma.
- Chronic myeloid leukaemia.
- Colorectal cancer.
- Breast cancer.
Professional memberships
- German Society for Haematology and Oncology.
- American Society of Hematology.
- Scientific advisory board of the Aplastic Anemia and Myelodysplastic Syndromes Foundation, Rockville, Maryland, USA.
Scientific consultancy
- AMGEN Corp.
- Novartis SpA.
- Celgene Corp.
- GlaxoSmithKline.
- Johnson & Johnson.
Regulatory and oversight activities
- US Food and Drug Administration, 30 November–4 December 2005.
- European Medicines Agency, 30 May–2 June 2006.
- Oversight of clinical drug studies in North Rhine-Westphalia, 13 January 2010.
Publications and editorial work
- More than 100 publications in scientific journals and books, including The New England Journal of Medicine, Blood and Journal of Clinical Oncology.
- Member of the editorial board of Journal of Clinical Oncology from 2013 to 2016, the official journal of the American Society of Clinical Oncology (ASCO).
